Sharp Therapeutics Corp.
SHRXF
$3.00
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 559.10K | -3.25M | -112.70K | -112.70K | -1.81M |
| Total Depreciation and Amortization | 23.00K | 26.90K | 24.90K | 24.90K | 8.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.95M | 1.99M | -898.00K | -898.00K | 657.10K |
| Change in Net Operating Assets | 24.60K | -152.60K | -197.30K | -197.30K | 461.20K |
| Cash from Operations | -1.35M | -1.39M | -1.18M | -1.18M | -678.50K |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | 16.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 2.60K | 2.60K | -- |
| Cash from Investing | -- | -- | 2.60K | 2.60K | 16.60K |
| Total Debt Issued | -- | -- | 475.00K | 475.00K | 1.25M |
| Total Debt Repaid | -50.00K | -50.00K | -168.40K | -168.40K | -50.00K |
| Issuance of Common Stock | 2.48M | -- | 2.48M | 2.48M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 14.80K | 14.80K | -- |
| Cash from Financing | 2.43M | -50.00K | 2.80M | 2.80M | 1.20M |
| Foreign Exchange rate Adjustments | 45.90K | -26.00K | 3.00K | 3.00K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -500.00K |
| Net Change in Cash | 1.13M | -1.47M | 1.63M | 1.63M | 38.10K |